146 related articles for article (PubMed ID: 35606041)
21. Pathogenesis of lymphatic disease in bancroftian filariasis: a clinical perspective.
Dreyer G; Norões J; Figueredo-Silva J; Piessens WF
Parasitol Today; 2000 Dec; 16(12):544-8. PubMed ID: 11121854
[TBL] [Abstract][Full Text] [Related]
22. Impact of single dose of diethylcarbamazine and other antifilarial drug combinations on bancroftian filarial infection variables: assessment after 2 years.
Sunish IP; Rajendran R; Mani TR; Munirathinam A; Reuben R; Dash AP
Parasitol Int; 2006 Sep; 55(3):233-6. PubMed ID: 16807079
[TBL] [Abstract][Full Text] [Related]
23. Randomised placebo-controlled comparison of ivermectin and albendazole alone and in combination for Wuchereria bancrofti microfilaraemia in Haitian children.
Addiss DG; Beach MJ; Streit TG; Lutwick S; LeConte FH; Lafontant JG; Hightower AW; Lammie PJ
Lancet; 1997 Aug; 350(9076):480-4. PubMed ID: 9274584
[TBL] [Abstract][Full Text] [Related]
24. Pharmacokinetics, safety, and efficacy of a single co-administered dose of diethylcarbamazine, albendazole and ivermectin in adults with and without Wuchereria bancrofti infection in Côte d'Ivoire.
Edi C; Bjerum CM; Ouattara AF; Chhonker YS; Penali LK; Méité A; Koudou BG; Weil GJ; King CL; Murry DJ
PLoS Negl Trop Dis; 2019 May; 13(5):e0007325. PubMed ID: 31107869
[TBL] [Abstract][Full Text] [Related]
25. Effects of ivermectin and diethylcarbamazine on microfilariae and overall microfilaria production in bancroftian filariasis.
Stolk WA; VAN Oortmarssen GJ; Pani SP; DE Vlas SJ; Subramanian S; DAS PK; Habbema JD
Am J Trop Med Hyg; 2005 Nov; 73(5):881-7. PubMed ID: 16282298
[TBL] [Abstract][Full Text] [Related]
26. Albendazole for lymphatic filariasis.
Addiss D; Critchley J; Ejere H; Garner P; Gelband H; Gamble C;
Cochrane Database Syst Rev; 2004; (1):CD003753. PubMed ID: 14974034
[TBL] [Abstract][Full Text] [Related]
27. An open label, block randomized, community study of the safety and efficacy of co-administered ivermectin, diethylcarbamazine plus albendazole vs. diethylcarbamazine plus albendazole for lymphatic filariasis in India.
Jambulingam P; Kuttiatt VS; Krishnamoorthy K; Subramanian S; Srividya A; Raju HKK; Rahi M; Somani RK; Suryaprakash MK; Dwivedi GP; Weil GJ
PLoS Negl Trop Dis; 2021 Feb; 15(2):e0009069. PubMed ID: 33591979
[TBL] [Abstract][Full Text] [Related]
28. Endpoints for lymphatic filariasis programs.
Grady CA; de Rochars MB; Direny AN; Orelus JN; Wendt J; Radday J; Mathieu E; Roberts JM; Streit TG; Addiss DG; Lammie PJ
Emerg Infect Dis; 2007 Apr; 13(4):608-10. PubMed ID: 17553278
[TBL] [Abstract][Full Text] [Related]
29. Children and adolescents infected with Wuchereria bancrofti in Greater Recife, Brazil: a randomized, year-long clinical trial of single treatments with diethylcarbamazine or diethylcarbamazine-albendazole.
Rizzo JA; Belo C; Lins R; Dreyer G
Ann Trop Med Parasitol; 2007 Jul; 101(5):423-33. PubMed ID: 17550648
[TBL] [Abstract][Full Text] [Related]
30. A triple-drug treatment regimen to accelerate elimination of lymphatic filariasis: From conception to delivery.
Weil GJ; Jacobson JA; King JD
Int Health; 2020 Dec; 13(Suppl 1):S60-S64. PubMed ID: 33349879
[TBL] [Abstract][Full Text] [Related]
31. Is anthelmintic resistance a threat to the program to eliminate lymphatic filariasis?
McCarthy J
Am J Trop Med Hyg; 2005 Aug; 73(2):232-3. PubMed ID: 16103580
[No Abstract] [Full Text] [Related]
32. Prevalence of Lymphatic Filariasis and Treatment Effectiveness of Albendazole/ Ivermectin in Individuals with HIV Co-infection in Southwest-Tanzania.
Kroidl I; Saathof E; Maganga L; Clowes P; Maboko L; Hoerauf A; Makunde WH; Haule A; Mviombo P; Pitter B; Mgeni N; Mabuye J; Kowuor D; Mwingira U; Malecela MN; Löscher T; Hoelscher M
PLoS Negl Trop Dis; 2016 Apr; 10(4):e0004618. PubMed ID: 27070786
[TBL] [Abstract][Full Text] [Related]
33. Efficacy, Safety, and Pharmacokinetics of Coadministered Diethylcarbamazine, Albendazole, and Ivermectin for Treatment of Bancroftian Filariasis.
Thomsen EK; Sanuku N; Baea M; Satofan S; Maki E; Lombore B; Schmidt MS; Siba PM; Weil GJ; Kazura JW; Fleckenstein LL; King CL
Clin Infect Dis; 2016 Feb; 62(3):334-341. PubMed ID: 26486704
[TBL] [Abstract][Full Text] [Related]
34. Evidence for the use of albendazole for the elimination of lymphatic filariasis.
Sunish IP; Rajendran R; Mani TR; Dash AP; Tyagi BK
Lancet Infect Dis; 2006 Mar; 6(3):125-6. PubMed ID: 16500593
[No Abstract] [Full Text] [Related]
35. Lymphatic pathology in asymptomatic and symptomatic children with Wuchereria bancrofti infection in children from Odisha, India and its reversal with DEC and albendazole treatment.
Kar SK; Dwibedi B; Das BK; Agrawala BK; Ramachandran CP; Horton J
PLoS Negl Trop Dis; 2017 Oct; 11(10):e0005631. PubMed ID: 29059186
[TBL] [Abstract][Full Text] [Related]
36. Changes in circulating parasite antigen levels after treatment of bancroftian filariasis with diethylcarbamazine and ivermectin.
Weil GJ; Lammie PJ; Richards FO; Eberhard ML
J Infect Dis; 1991 Oct; 164(4):814-6. PubMed ID: 1894943
[TBL] [Abstract][Full Text] [Related]
37. Duplex Doppler sonographic assessment of the effects of diethylcarbamazine and albendazole therapy on adult filarial worms and adjacent host tissues in Bancroftian filariasis.
Hussein O; El Setouhy M; Ahmed ES; Kandil AM; Ramzy RM; Helmy H; Weil GJ
Am J Trop Med Hyg; 2004 Oct; 71(4):471-7. PubMed ID: 15516645
[TBL] [Abstract][Full Text] [Related]
38. Mathematical modelling of lymphatic filariasis elimination programmes in India: required duration of mass drug administration and post-treatment level of infection indicators.
Jambulingam P; Subramanian S; de Vlas SJ; Vinubala C; Stolk WA
Parasit Vectors; 2016 Sep; 9(1):501. PubMed ID: 27624157
[TBL] [Abstract][Full Text] [Related]
39. A study on the provocative day test effect of ivermectin and albendazole on nocturnal periodic Wuchereria bancrofti microfilaraemia.
Dunyo SK; Nkrumah FK; Simonsen PE
Trans R Soc Trop Med Hyg; 1999; 93(6):608-10. PubMed ID: 10717746
[TBL] [Abstract][Full Text] [Related]
40. Potential Value of Triple Drug Therapy with Ivermectin, Diethylcarbamazine, and Albendazole (IDA) to Accelerate Elimination of Lymphatic Filariasis and Onchocerciasis in Africa.
Fischer PU; King CL; Jacobson JA; Weil GJ
PLoS Negl Trop Dis; 2017 Jan; 11(1):e0005163. PubMed ID: 28056015
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
